Author

Breanna Estby

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5073972406

Association of lymphocyte to monocyte ratio with clinical response and survival in patients with relapsed, aggressive non-Hodgkin lymphoma treated with axicabtagene ciloleucel CAR-T.

2020 · Abdullah S. Al Saleh, Sangeetha Gandhi, et al. · Journal of Clinical Oncology · 1

Impact of type of salvage therapy (ST) and response to bridging therapy (BT) on CAR-T therapy outcomes for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma (NHL).

2020 · Arushi Khurana, Abdullah S. Al Saleh, et al. · Journal of Clinical Oncology · 1

Baseline Hypoalbuminemia Does Not Appear to be an Adverse Prognostic Factor in Patients with Relapse/Refractory B-Cell Lymphomas Treated with Axicabtagene Ciloleucel (axi-cel)

2019 · Megan Melody, Sangeetha Gandhi, et al. · Blood · 1

Decrease in Serum Albumin Level Predicts Onset of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) in Patients with Relapsed/Refractory B-Cell Lymphomas Treated with Axicabtagene Ciloleucel (axi-cel)

2020 · Zaid Abdel Rahman, Sangeetha Gandhi, et al. · Transplantation and Cellular Therapy

Works count: 4

Citation count: 3

H-index: 1

I10-index: